EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 28 filers reported holding EVOKE PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $67,000 | -29.5% | 36,700 | 0.0% | 0.00% | – |
| Q4 2020 | $95,000 | -44.8% | 36,700 | 0.0% | 0.00% | – |
| Q3 2020 | $172,000 | +32.3% | 36,700 | 0.0% | 0.00% | – |
| Q2 2020 | $130,000 | +202.3% | 36,700 | 0.0% | 0.00% | – |
| Q1 2020 | $43,000 | -27.1% | 36,700 | 0.0% | 0.00% | – |
| Q4 2019 | $59,000 | +84.4% | 36,700 | 0.0% | 0.00% | – |
| Q3 2019 | $32,000 | +39.1% | 36,700 | 0.0% | 0.00% | – |
| Q2 2019 | $23,000 | -58.2% | 36,700 | 0.0% | 0.00% | – |
| Q1 2019 | $55,000 | -39.6% | 36,700 | 0.0% | 0.00% | – |
| Q4 2018 | $91,000 | -16.5% | 36,700 | 0.0% | 0.00% | – |
| Q3 2018 | $109,000 | +18.5% | 36,700 | 0.0% | 0.00% | – |
| Q2 2018 | $92,000 | +21.1% | 36,700 | 0.0% | 0.00% | – |
| Q1 2018 | $76,000 | -8.4% | 36,700 | 0.0% | 0.00% | – |
| Q4 2017 | $83,000 | -32.5% | 36,700 | 0.0% | 0.00% | – |
| Q3 2017 | $123,000 | +30.9% | 36,700 | 0.0% | 0.00% | – |
| Q2 2017 | $94,000 | -17.5% | 36,700 | 0.0% | 0.00% | – |
| Q1 2017 | $114,000 | +54.1% | 36,700 | 0.0% | 0.00% | – |
| Q4 2016 | $74,000 | -10.8% | 36,700 | 0.0% | 0.00% | – |
| Q3 2016 | $83,000 | -66.9% | 36,700 | 0.0% | 0.00% | – |
| Q2 2016 | $251,000 | +34.2% | 36,700 | 0.0% | 0.00% | – |
| Q1 2016 | $187,000 | +54.5% | 36,700 | 0.0% | 0.00% | – |
| Q4 2015 | $121,000 | +11.0% | 36,700 | 0.0% | 0.00% | – |
| Q3 2015 | $109,000 | -43.2% | 36,700 | 0.0% | 0.00% | – |
| Q2 2015 | $192,000 | -21.0% | 36,700 | 0.0% | 0.00% | – |
| Q1 2015 | $243,000 | 0.0% | 36,700 | 0.0% | 0.00% | – |
| Q4 2014 | $243,000 | – | 36,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 242,500 | $1,962,000 | 1.69% |
| SOPHROSYNE CAPITAL LLC | 49,000 | $397,000 | 0.40% |
| LMR Partners LLP | 23,882 | $187,000 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,276 | $80,000 | 0.00% |
| BlackRock Investment Management, LLC | 489 | $4,000 | 0.00% |
| MORGAN STANLEY | 500 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 84 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 48,394 | $378,000 | 0.00% |
| UBS AG | 727 | $6,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,500 | $271,000 | 0.00% |